Incidence and risk factors for capecitabine-induced symptomatic cardiotoxicity: a retrospective study of 452 consecutive patients with metastatic breast cancer

OBJECTIVES: Case reports of capecitabine cardiotoxicity resemble those seen with intravenous 5-fluorouracil (5-FU) with chest pain as the predominant manifestation, but few studies of capecitabine cardiotoxicity are available. We aimed to determine the incidence of symptomatic cardiotoxicity from ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Polk, Anne, Shahmarvand, Nahid, Vistisen, Kirsten, Vaage-Nilsen, Merete, Larsen, Finn Ole, Schou, Morten, Nielsen, Dorte Lisbeth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5073470/
https://www.ncbi.nlm.nih.gov/pubmed/27798021
http://dx.doi.org/10.1136/bmjopen-2016-012798

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5073470/
https://www.ncbi.nlm.nih.gov/pubmed/27798021
http://dx.doi.org/10.1136/bmjopen-2016-012798

Ejemplares similares